Oppenheimer raised the firm’s price target on iRhythm (IRTC) to $130 from $120 and keeps an Outperform rating on the shares following quarterly results. The firm notes iRhythm reaffirmed its pre-release FY25 guidance of $675-685M vs. its/consensus’ original $680M forecasts.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IRTC:
- iRhythm price target raised to $133 from $126 at Baird
- iRhythm price target raised to $135 from $120 at BTIG
- Strong Sales Growth and Strategic Expansion Drive Buy Rating for iRhythm Technologies
- iRhythm price target raised to $104 from $86 at Wells Fargo
- iRhythm Technologies Reports Robust 2024 Growth